7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with 3-methylcholanthrene in 1 studies
| Studies (7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride) | Trials (7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride) | Recent Studies (post-2010) (7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride) | Studies (3-methylcholanthrene) | Trials (3-methylcholanthrene) | Recent Studies (post-2010) (3-methylcholanthrene) |
|---|---|---|---|---|---|
| 17 | 2 | 0 | 7,215 | 1 | 158 |
| Protein | Taxonomy | 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride (IC50) | 3-methylcholanthrene (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.544 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YJ; Kim, WB; Kwon, JW; Lee, HJ; Lee, MG; Yang, J | 1 |
1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and 3-methylcholanthrene
| Article | Year |
|---|---|
Pharmacokinetic changes of M1, M2, M3 and M4 after intravenous administration of a new anthracycline, DA-125, to rats pretreated with phenobarbital, 3-methylcholanthrene, chloramphenicol, or SKF-525A.
Topics: Animals; Anthracyclines; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antineoplastic Agents; Carcinogens; Carotid Arteries; Chloramphenicol; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Injections, Intravenous; Jugular Veins; Male; Methylcholanthrene; Phenobarbital; Proadifen; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley | 1998 |